Leef Brands (LEEEF) Raw Materials (2024 - 2026)
Leef Brands (LEEEF) reported Raw Materials of $1.2 million for Q1 2026, up 34.35% sequentially from $889784.0 in Q4 2025.
Leef Brands (LEEEF) Raw Materials (2024 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 3 years of Raw Materials data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Raw Materials changed N/A year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (changed N/A YoY), and the FY2025 full-year result was $889784.0, down 34.09% from the prior year.
- Raw Materials advanced to $1.2 million in Q1 2026, from $889784.0 in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $1.3 million in Q4 2024 to a low of $889784.0 in Q4 2025.
- A 3-year average of $1.1 million and a median of $1.2 million in 2026 frame the typical range for Raw Materials.
- Peak annual rise in Raw Materials reached 34.09% in 2025, while the deepest fall reached 34.09% in 2025.
- Tracing LEEEF's Raw Materials over 3 years: stood at $1.3 million in 2024, then plunged by 34.09% to $889784.0 in 2025, then jumped by 34.35% to $1.2 million in 2026.
- Business Quant data shows LEEEF's Raw Materials at $1.2 million in Q1 2026, $889784.0 in Q4 2025, and $1.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Leef Brands | 51.94 Mn | 46.18 Mn | 4.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 889,784.00 |
| Dec 31, 2024 | 1.35 Mn |